Donepezil as a safe alternative treatment after maculo-papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data

Psychogeriatrics. 2024 Sep;24(5):1180-1183. doi: 10.1111/psyg.13166. Epub 2024 Jul 25.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cholinesterase Inhibitors* / adverse effects
  • Cholinesterase Inhibitors* / therapeutic use
  • Donepezil* / adverse effects
  • Donepezil* / therapeutic use
  • Drug Eruptions / etiology
  • Female
  • Humans
  • Lewy Body Disease* / drug therapy
  • Male
  • Pharmacovigilance*
  • Rivastigmine* / adverse effects
  • Rivastigmine* / therapeutic use
  • Treatment Outcome

Substances

  • Donepezil
  • Rivastigmine
  • Cholinesterase Inhibitors